FDA Approved: CAMPTOSAR — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for Camptosar (irinotecan hydrochloride) submitted by Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Camptosar (irinotecan)

Snippet

SUPPL AP for CAMPTOSAR (IRINOTECAN HYDROCHLORIDE)